Immunoassays development for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes

Clinical Chemistry

Volumn 52, Issue 3, 2006, Pages 398-404

  Qin, Qiu Ping ^a   Kokkala, Saara ^a   Lund, Juha ^a   Tamm, Natalia ^b   Qin, Xuezhong ^c   Lepäntalo, Mauri ^d   Pettersson, Kim ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b HyTest Ltd   (Finland)

^c Jerry L Pettis Memorial VA Medical Center   (United States)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MAJOR BASIC PROTEIN; MONOCLONAL ANTIBODY; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEIN PRECURSOR; PROTEIN SUBUNIT; RECOMBINANT PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ANTIBODY SPECIFICITY; ARTICLE; CASE REPORT; DIAGNOSTIC ACCURACY; FEMALE; FLUOROMETRY; HEART INFARCTION; HUMAN; IMMUNOASSAY; MALE; PREGNANCY COMPLICATION; PROTEIN CONFORMATION; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION; ACUTE DISEASE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PREGNANCY; PROTEIN BINDING; SYNDROME;

ACUTE DISEASE; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CORONARY DISEASE; EOSINOPHIL MAJOR BASIC PROTEIN; EPITOPES; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROTEIN BINDING; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; SYNDROME;

EID: 33644546380     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.058396     Document Type: Article

References (29)

1. Lin TM, Galbert SP, Kiefer D, Spellacy WN, Gall S. Characterization of four human pregnancy-associated plasma proteins. Am J Obstet Gynecol 1974;118:223-36.
2. Folkersen J, Grudzinskas JG, Hindersson P, Teisner B, Westergaard JG. Pregnancy-associated plasma protein A: circulating levels during normal pregnancy. Am J Obstet Gynecol 1981;139:910-4.
3. Wald N, Stone R, Cuckle HS, Grudzinskas JG, Barkai G, Brambati B, et al. First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome. Br Med J 1992;305:28.
4. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-13.
5. Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW, et al. Association of extreme first-trimester free human chorionic gonadotropin-β, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191:1452-8.
6. Smith GC, Crossley JA, Aitken DA, Pell JP, Cameron AD, Connor JM, et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA 2004;292:2249-54.
7. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022-9.
8. Qin QP, Laitinen P, Majamaa-Voltti K, Eriksson S, Kumpula EK, Pettersson K. Release patterns of pregnancy associated plasma protein A (PAPP-A) in patients with acute coronary syndromes. Scand Cardiovasc J 2002;36:358-61.
9. Lund J, Qin QP, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P, et al. Circulating pregnancy associated plasma protein A (PAPP-A) predicts outcome in patients with acute coronary syndromes but no troponin I elevation. Circulation 2003;108:1924-6.
10. Heeschen C, Dimmeler S, Hamm CW, FichtIscherer S, Simoons ML, Zeiher AM. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes. Comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005;45:229-37.
11. Overgaard MT, Sorensen ES, Stachowiak D, Boldt HB, Kristensen L, Sottrup-Jensen L, et al. Complex of pregnancy-associated plasma protein-A and the proform of eosinophil major basic protein. Disulfide structure and carbohydrate attachment. J Biol Chem 2003;278:2106-17.
12. Qin QP, Kokkala S, Lund J, Tamm N, Voipio-Pulkki LM, Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 2005;51:75-83.
13. Glerup S, Boldt HB, Overgaard MT, Sottrup-Jensen L, Giudice LC, Oxvig C. Proteinase inhibition by proform of eosinophil major basic protein (proMBP) is a multistep process of intra- and intermolecular disulfide rearrangements. J Biol Chem 2005;280:9823-32.
14. Bersinger NA, Meisser A, Bessou T, Seguin P, Birkhauser MH, Bischof P. Production and characterization of monoclonal antibodies against pregnancy-associated plasma protein A. Mol Hum Reprod 1999;5:675-81.
15. Qin QP. Maternal serum screening for Down syndrome in the first trimester with special emphasis on pregnancy associated plasma protein A [PhD thesis]. Turku, Finland: University of Turku, 1998.
16. Laterza OF, Cameron SJ, Chappell D, Sokoll U, Green GB. Evaluation of pregnancy-associated plasma protein A as a prognostic indicator in acute coronary syndrome patients. Clin Chim Acta 2004;348:163-9.
17. Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez M, Ferrer J, Vargas M. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction. Clin Biochem 2005;38:180-2.
18. Pettersson K, Soderholm JR. Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry. Clin Chem 1990;36:1928-33.
19. Sivanandam AS, Mohan S, Kapur S, Kita H, Lau KH, Bagi G, et al. Covalent interaction between proform of eosinophil major basic protein (proMBP) and pregnancy-associated plasma protein-A (PAPP-A) is a cell-mediated event and required for proMBP inhibition of the catalytic activity of PAPP-A. Arch Biochem Biophys 2004;423:343-50.
20. Qin QP, Christiansen M, Oxvig C, Pettersson K, Sottrup-Jensen L, Koch C, et al. Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin Chem 1997;43:2323-32.
21. Qin QP, Christiansen M, Pettersson K. Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. Clin Chem 2002;48:473-83.
22. Qin QP, Lovgren T, Pettersson K. Development of highly fluorescent detection reagents for the construction of ultrasensitive immunoassays. Anal Chem 2001;73:1521-9.
23. Overgaard MT, Haaning J, Boldt HB, Olsen IM, Laursen LS, Christiansen M, et al. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 2000;275:31128-33.
24. Overgaard MT, Glerup S, Boldt HB, Rodacker V, Olsen IM, Christiansen M, et al. Inhibition of proteolysis by the proform of eosinophil major basic protein (proMBP) requires covalent binding to its target proteinase. FEBS Lett 2004;560:147-52.
25. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 1993;268:12243-6.
26. Oxvig C, Haaning J, Kristensen L, Wagner JM, Rubin I, Stigbrand T, et al. Identification of angiotensinogen and complement C3dg as novel proteins binding the proform of eosinophil major basic protein in human pregnancy serum and plasma. J Biol Chem 1995;270:13645-51.
27. Bohn H, Chard T, Grudzinskas JG, Klopper A, Rosen S, Schultz-Larsen P, et al. Reference preparation for assay of some pregnancy and cancer associated proteins. Lancet 1980;ii:796.
28. Bradbury AR, Marks JD. Antibodies from phage antibody libraries [Review]. J Immunol Methods 2004;290:29-49.
29. Woodman R, Yeh JT, Laurenson S, Ferrigno PK. Design and validation of a neutral protein scaffold for the presentation of peptide aptamers. J Mol Biol 2005;352:1118-33.